Product Information
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB is a generic product labeled by Larken Laboratories, Inc., priced at $0.5709 per EA under NDC 68047072101. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Dec 4, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 50 mg/1; mg/1
Manufacturer
Larken Laboratories, Inc.NDC
68047072101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITALApproval Type
Generic (ANDA)
FDA Application
ANDA203484FDA Approved
12/4/2015
TE Code
AA
On Market Since
12/4/2015
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has been published 542 times since May 18, 2016, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5709 per EA |
|---|---|
| All-time high | $1.2418 (Jun 15, 2016) |
| All-time low | $0.4121 (Nov 20, 2024) |
| 52-week high | $0.7122 |
| 52-week low | $0.5411 |
| Median price | $0.9298 |
| Average price | $0.9059 |
| Largest weekly change | +47.5% (Sep 21, 2022) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Larken Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
butalbital and acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Barbiturate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, manufactured by Larken Laboratories, Inc., is $0.5709 per EA (NDC 68047072101), effective Sep 30, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has declined 54.0%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
Since May 18, 2016, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has ranged from a low of $0.4121 (Nov 20, 2024) to a high of $1.2418 (Jun 15, 2016), with a median of $0.9298 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB (NDC 68047072101) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.